MORGAN SOUTHERN: Open Payments
NPI 1396444568 · GARY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 10 payments from 9 companies in 2025. Trend: 2023 $97 · 2024 $148 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Neurelis, Inc. | 1 | $27 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Organogenesis Inc. | 1 | $23 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $20 |
| TG Therapeutics, Inc. | 1 | $17 |
Products named: Ocrevus Zunovo, HYQVIA, VALTOCO, FYCOMPA, Dysport, PURAPLY WOUND MATRIX, ULTOMIRIS, CLEVIPREX.
Industry payments across IN — which companies pay providers there.
